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Pets and cockroaches: two increasing causes of
respiratory allergy in indoor environments.
Characteristics of airways sensitization and
prevention strategies
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Department of Chest Diseases, Division of Pneumology and Allergology, ‘A.Cardarelli’ Hospital, Naples, Italy
The increasing prevalence of allergic sensitization to indoor allergens such as dust mites, pets and cockroaches is the
result of the changes in indoor environments induced by human activities. The Westernized lifestyle and the
increasing time spent indoors determine a reduction in natural air ventilation and, consequently, higher levels of
allergen concentrations and longer exposure to allergens.
The major cat allergen Fel d 1 is carried by small-dimension particles (5 5 mm diameter) that readily become
airborne and persist immodified for a long time.
Fel d 1 must be considered a ubiquitous allergen because it has been found in indoor environments and even in
public places where a cat has never been kept. Recent research has demonstrated that clothing of cat owners may
contribute to the dispersal of Fel d 1 in cat-free environments. Therefore, washing Fel d 1-contaminated clothes
should be considered a simple and effective method for removing this allergen from clothing and, consequently,
reducing the risk of Fel d 1 dispersion.
Cockroach allergens constitute another important cause of environment-related respiratory allergy and may
trigger asthma exacerbations in sensitized individuals. In the prevention of cockroach allergy, the use of chemical
agents associated with an intensive vacuum cleaning of indoor environments is an important tool in removing
cockroach material containing allergenic proteins.
Early recognition of allergy-predisposed babies, monitoring indoor allergens and adequate strategies of allergen
avoidance are likely to be important means for reducing the prevalence of bronchial asthma.
Key words: indoor allergens; respiratory allergy; bronchial asthma; Fel d 1; cat allergen; Can f 1; cockroach;
allergen avoidance; prevention.
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Different epidemiological studies carried out world-wide in
the last two decades have shown an increasing prevalence of
allergic respiratory diseases, mainly bronchial asthma, even
though highly effective anti-inflammatory and symptomatic
drugs are available (1,2).
This trend is present not only in industrialized world, but
also in some developing countries where these diseases were
absent only few years ago (3).
Although many factors have been suggested to play an
important role in the increasing rate of atopic diseases inReceived 29 December 1999 and accepted in revised form 28 June
2000. Published online 26 September 2000.
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0954-6111/00/111109+10 $35?00/0the general population (Table 1), a large body of experi-
mental and clinical evidence has demostrated the impact on
developing respiratory allergy induced by different changes
in outdoor and indoor environments induced by human
activities and the Westernized lifestyle (4–10). For example,
indoor environments, usually considered free from air
contaminants, contain several sensitizing and/or irritating
agents which may increase airway hyperreactivity in
predisposed individuals (Table 2).
However, epidemiological evidences from various
sources suggest that exposure to high levels of inhalant
allergens such as Der p 1, Fel d 1, Bla g 1 and Bla g 2 early
in life, particularly during the first few years, represent an
important risk factor for developing atopic bronchial
asthma in children (11–16).
In contrast, it has recently been suggested that living in
rural areas with close animal contact is associated to lower
incidence of allergy (17,18), and early exposure to pet
allergens may produce a ‘protective’ effect for later
development of allergy (19).# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. General theories suggesting the increasing rate of
atopic diseases in the general population
. Low birth weight (74)
. Decrease of some common infections in the first phase
of life (112,113)
. Use of vaccination against some bacterial or viral
agents (114)
. Early use of antibiotics (113)
. Changes in the intestinal flora (115)
. Early exposure to indoor and outdoor air pollution
(116)
. Characteristics of intrauterine immunity (116)
. Diet (117)
. Early discontinuation of breast feeding (118)
. Socioeconomic level (119)
1110 G. LICCARDI ET AL.The relationship between exposure to allergens, mainly if
they derive from indoors, and development of bronchial
obstruction in allergic patients is complex. In fact, in each
patient asthma symptoms are induced by different doses of
allergen and also by aspecific agents (20,21). However, the
general opinion is that this disorder is more severe in
sensitized patients who are exposed to a higher level of
allergen (21).
In this review we will discuss the main characteristics of
allergic sensitization to allergens produced by domestic
animals and cockroaches, and some aspects of environ-
mental prevention from these materials.
Characteristics of allergic
sensitization to pet and cockroach
allergens
DOMESTIC ANIMALS
Sensitization to allergens derived from different mammals
and birds is a common occupational airway disease in
laboratory workers (22). Moreover, the growing frequency
in keeping furred pets (mainly cats and dogs) inside the
house have increased the level of exposure to theseTABLE 2. Changes in indoor environment and lifestyle that may i
chemical agents
. The use of energy saving systems applied on doors and win
indoor humidity and pollutant levels (110,120)
. Increasing use of upholstered furnitures and wall-to wall c
. Central heating systems and/or humidifiers (110,121)
. New building materials, presence of many new compound
. Increasing time spent indoors (domestic environments, o
. Sedentary life, especially during childhood (124)
. Increasing practice, in many industrialized countries, of ke
. Deterioration of the environment in many urban and subuallergens. Also rebuilding work on houses and the time
spent indoors are important factors (23).
Cats and dogs represent the main source of pet allergens
in many industrialized countries (24). In some areas of the
world, 50–70% of children with bronchial asthma are
sensitized to domestic animals (25). Keeping furred pets
indoors has become more common over recent decades,
especially in Northern Europe where it has been estimated
that 23–34% of school children own a dog and/or a cat
(26,27).
A high rate of allergic sensitization to pet allergens has
also been found in some geographical areas with cold
climate and low humidity (28). In these climatic conditions
exposure to mite and cockroach allergens is rare.
Recently, Noertiojo et al. (29) demonstrated that among
the various types of pets, cat ownership is associated with
the highest prevalence of current asthma.
Cats produce seven to eight different proteins. The main
cat allergen Fel d 1 is able to induce specific IgE production
in about 85% of sensitized patients. The allergen (MW 36
kDa) is constituted by two subunits, each one containing
two chains of 70 and 90–92 amino acids. The physiological
function of Fel d 1 is still unknown. It is likely that this
protein plays a role in the protection of epithelia or in
pheromonal regulation (30). It is produced in large quantity
by sebaceous glands, salivary glands, basal squamous
epithelial cells in cat skin (24) and in cat anal glands (31).
Carayol et al. (32) demonstrated that cat facial skin
constitutes a major area of Fel d 1 production (about 10
times greater than chest) and that levels of this allergen on
fur correlate with skin content.
A Fel d 1-like molecule has been demostrated in the big
cats such as Siberian tiger, lion, puma and jaguar (33),
suggesting that this molecule may have biological signifi-
cance (30). Chain 1 of the Fel d 1 molecule has now been
classified as a member of the lipocalin family of proteins
(34), which are globular proteins of low molecular weight
(about 17–20 kDa). These proteins are present in skin and
secretions (urine and saliva). Moreover, Fel d 1 chain 1
possesses some sequence homology with rabbit utero-
globulin (about 28%) (34) and with a mouse salivary
protein (about 50%) (35).
Evidence suggests that the production of these lipocalins
is under complex hormonal control. It has been shown that
Fel d 1 allergen production by sebaceous glands of malencrease respiratory allergic diseases induced by allergens and
dows? reduction of indoor natural ventilation? increased
arpets (110)
s at home (chemicals) (122,123)
ces, means of transport, etc.) (124)
eping furred pets indoors (23)
rban areas (125)
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castration (36,37).
Recent studies have confirmed that hormonal control
causes a higher Fel d 1 production in male than in female
cats. Moreover, castration in females does not induce any
change in Fel d 1 concentration on cat fur (38,39).
However, the Fel d 1 levels produced by castrated male
cats are sucient to induce respiratory symptoms in
sensitized patients (40).
However, patients allergic to cats and dogs frequently
display IgE reactivity against allergenic proteins from
different animals. This finding suggests the possibility of
cross-reactions between common allergenic determinants
(41).
Shared IgE epitopes of the major cat and dog allergens
may provide an explanation for the common clinical
observation that respiratory allergies to these two species
of animals are frequently associated (41).
Albumins and other low molecular weight proteins have
been recognized as relevant cross-reactive allergens when
using immunoblotting and RAST inhibition techniques
(30,36,42).
Heat stability is characteristic of pet allegens (Fel d 1 and
Can f 1 ). In fact, only 30% and 50%, respectively, of these
allergens are modified after dry heat exposure (about
1408C) for 60 min (43).
The knowledge of aerodynamic properties of particles
carrying furred pet allergens is crucial to understanding the
modality of inducing clinical symptoms (44). The main cat
allergen is carried in the air of indoor environments by large
particles of about 10 mm diameter (75%) and by smaller
particles (55 mm diameter) (25%). These small allergen-
carrying particles become readily airborne and remain so
for long periods, after minimal disturbance (45,46).
Aerodynamic characteristics of the main dog allergen
(Can f 1) are similar to those of cat allergen (Fel d 1) (47).
In contrast, group 1/group 2 mite allergens and cockroach
allergens (Bla g 1 and Bla g 2) are carried by relatively large
particles (>10 mm diameter). For this reason these particles
can be detected in large amounts in the air of indoor
environments only after a strong disturbance (48). In
undisturbed conditions these allergens are found only in
their reservoir (23).
Differences in allergen-carrying particles are important.
For example, sensitized patients show a rapid onset of
conjunctival and respiratory symptoms a few minutes after
entering a house containing a pet. However, mite-allergic
subjects in undisturbed conditions usually inhale more
constant amounts of allergenic materials and consequently
exhibit a perennial pattern of respiratory symptoms (45).
Obviously, the knowledge of sources and aerodynamic
characteristics of allergen-carryng particles is crucial for
allergen avoidance strategies in indoor environments.
The use of air filtration devices are not useful in removing
mite and cockroach allergens from their reservoir but may
constitute an important means to reduce the amount of pet
allergens from the air by approximately 2–4-fold (49).
Recent studies have demonstrated that the application of
air cleaners in living rooms and bedrooms of young
asthmatics sensitized and exposed to pets in the house isassociated with a significant reduction in airway hyper-
responsiveness and a decrease in peak flow amplitude (50).
Platts Mills (23) demonstrated that the levels of indoor
allergen concentrations that may determine sensitization
and/or bronchial symptoms in sensitized individuals are
different. For example, 2 mg Der p 1 g71 of dust has been
suggested to constitute the threshold amount of this
allergen, inducing sensitization and 10mg g71 to represent
the threshold concentration of Der p 1 which may trigger
asthma exacerbations in mite-allergic individuals (23).
Other authors suggested that the threshold concentration
of Der p 1-inducing airways sensitization should be lower
because highly susceptible young children may become
sensitized at concentrations 10–100 times lower than
2mg g71 (51).
In cat allergen-sensitized patients, the threshold concen-
tration of Fel d 1 inducing sensitization and triggering
bronchial obstruction should be 1mg g71 and 8 mg g71 of
dust, respectively (24,44). There are conflicting opinions on
cat allergen threshold concentrations because the amount
of this allergen in the dust may not represent the real level
of environmental exposure. Since Fel d 1 can be detected in
large amounts in the air of indoor environments, the
evaluation of this threshold levels should be determined
using airborne samplers (52,53). Peterson et al. (54)
demonstrated that there is little correlation between air
and dust concentrations of the major indoor allergens
(Fel d 1, Der f 1, Der p 1). They also suggested the necessity
of performing two or three samples of air and dust/year to
characterize annual indoor allergen exposure.
Several studies have demonstrated that Fel d 1 can be
considered a ubiquitous allergen. This protein has been
found in indoor environments and in public places, such as
hospitals, schools and public transport where a cat has
never been kept (55–66). Consequently, indirect exposure to
pet allergens in cat-free environments may also determine
airways sensitization and/or trigger asthmatic symptoms in
sensitized patients (55–57).
Last year, school became recognized as a risk environ-
ment for Swedish asthmatic children sensitized to cat
allergens, since school may constitute a site of indirect
exposure to these allergens (67,68). Indirect exposure to pet
allergens might be sucient to induce and/or maintain
respiratory symptoms in sensitized children since different
studies suggest an increase in non-specific bronchial
responsiveness after low dose allergen exposure (60,69,70).
Recently, we have shown that winter clothes (skirts and
trousers) of patients with a cat at home contain higher
amounts of Fel d 1 on their surfaces in comparison with
those of subjects who have a dog in the home and those of
control subjects without animals at home (71). As a
consequence, clothing may constitute an important means
for the distribution of this allergen in cat-free environments
(such as schools and public places) and a risk factor for
triggering asthma in cat-sensitized individuals.
Similar findings have also been demonstrated for dog
allergens (Can f 1) in the clothing and school environment
of Swedish school children (72). Even if dog produces
potent allergenic proteins, the prevalence of allergic
sensitization to these materials is lower than that induced
1112 G. LICCARDI ET AL.by cat allergens (73). This finding may be explained by the
fact that dogs frequently remains outdoors, whereas cats
are allowed to stay indoors (45).
The main dog allergen Can f 1 (MW 25 kDa) is able to
induce specific IgE production in about 70% of dog-allergic
individuals. This protein could play a physiological role in
the dog taste function (36). Another allergenic protein, Can
f 2 (MW 27 kDa), induces IgE production in only 23% of
dog sensitized patients (23).
COCKROACHES
Although different species of cockroaches may be found in
indoor environments, Blattella germanica, B. orientalis and
Periplaneta americana are the most common species world-
wide (75).
Blattella germanica lives in damp geographical areas and
in indoor environments warmed by central heating. Large
populations of cockroaches may be found especially in
urban and suburban areas of U.S.A. where cockroach
allergens are the second agent of indoor allergic sensitiza-
tion after Dermatophagoides pteronyssinus (458% of atopic
patients) (76–78). This is the reason why some studies have
demostrated that exposure to cockroach allergens may
constitute a relevant risk factor for emergency room visits
(79), asthma hospitalization (80) and accelerated decline in
FEV1 independent of airway hyperresponsiveness U.S.A.
(81). However recent research has also reported increasing
significance of cockroach sensitization in other countries
such as Switzerland, Spain and Northern Europe (Table 3 ).
In Italy, the prevalence of allergic sensitization to cock-
roaches in adults and children is similar, having been found
in 13% (82) and 12?7% (83) of atopic patients, respectively.
In Naples (Italy) the prevalence of allergic sensitization to
cockroach allergens is about 5% (84). The majority of
Neapolitan cockroach-sensitized subjects also exibit a
positive skin prick test to Dermatophagoides pteronyssinus
allergens (85). The possibility of an association between















Italy (Naples area) 4?6also found by others studies (86,87). Although some
authors have suggested a cross-reactivity between cock-
roach and mite allergens (87), other researchers believe that
this association is determined by cockroaches and mites co-
existence in the same indoor environments (86).
Cockroach allergens are found especially in faeces, saliva,
and in the whole body (88). These allergenic materials
persist for a long time in indoor environments even after
cockroach extermination (89). This behaviour is similar to
that of dust mites. The most common cockroach allergens
are produced by Blattella germanica (Bla g 1, Bla g 2, Bla g
4, Bla g 5) and Periplaneta americana (Per a 1, Per a 3) (23).
In these last few years, extensive studies have been carried
out to identify and clone cockroach allergens (90–93).
Previous data have demonstrated that there is a cross-
reactivity between B. germanica and P. americana extracts
on skin testing, although all cockroach cloned allergens
have been species-specific (94). Among these allergens only
Bla g 1 and Per a 1 are cross-reactive because they are
produced by both cockroach species. In any case their
structure has not been defined (95). Recently, Melen et al.
(96) have demonstrated that Per a 1 and Bla g 1 constitute a
family of structurally and antigenically related ‘Group 1’
allergens produced by B. germanica and P. americana.
Witteman et al. (97) suggested the possibility that
tropomyosin might constitute the cross-reacting allergen
in shrimp, mite and insects. In a recent study, Santos et al.
(98) have confirmed that P. americana tropomyosin showed
80%, 81% and 82% sequence identity to tropomyosin from
Dermatophagoides pteronyssinus, D. farinae and shrimp,
respectively. Bla g 5 (gluthatione transferase), a highly
sensitizing allergen, has been shown to be produced
especially from B. germanica when affected by chemical
agents (99). Bla g 5 is an allergen that possesses digestive
function.
In some geographical areas with cockroach infestation,
allergic sensitization to their allergens is very common,
mainly in children (78). The prevalence of this allergy in
children has been suggested to be associated with birth in
winter months. This probably happens because there is aens in some geographical areas
Author Reference
Sarpong et al. (1998) (77)
Mosimann et al. (1993) (126)
Sastre et al. (1996) (127)
Birnbaum et al. (1995) (86)
Eriksson et al. (1997) (87)
Hirsch et al. (2000) (128)
Gupta et al. (1990) (129)
Lan et al. (1998) (130)
Santos et al. (1999) (98)
Peruzzi et al. (1999)
Riario-Sforza et al. (1997)
(83)
(82)
Liccardi et al. (1998) (84)
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staying indoors longer, induced by climate (77).
The aerodynamic characteristics of particles carrying
cockroach allergens are similar to those involved in
carrying dust mite allergens (10mm diameter). For this
reason, these materials are found mainly in their reservoir
and become airborne only after a strong disturbance of
indoor environments (48).
Although threshold cockroach allergen levels for sentiza-
tion and/or induction of airway obstruction have not yet
been evaluated, it is likely that these levels are similar to
those of dust mite allergens (78).
Possible preventive strategies
DOMESTIC ANIMALS
The removal of allergenic materials produced by domestic
animals constitutes an important preventive measure not
only in patients sensitized to these allergens, but also in
subjects with dust mite allergy. The epithelia of domestic
animals represent an optimum food for dust mite popula-
tions. Consequently, the best way for preventing cat/dog
allergy is to relocate the animal and then to intensively use
air cleaners equipped with HEPA filters or vacuum cleaners
(100,101). The duration of this action is fundamental
because several studies have demonstrated the long
persistence of high levels of Fel d 1 in carpets (102) and
in mattresses (103) after the eviction of cats. Unfortunately,
many pet-sensitized patients, particularly children, refuse to
remove their animals. In these situations intensive avoid-
ance measures are necessary to reduce the degree of cat/dog
allergen exposure and to control respiratory symptoms
(45). Table 4 indicates the main measures to minimize
exposure to cat/dog allergens.
Studies demonstrating passive carrying of cat allergens
on clothes suggest that the removal of these proteins, by
using different modalities of cleaning, may be considered an
important tool for the prevention of the dispersal of petTABLE 4. Measures to minimize exposure to the allergens of cat
. Pets must be removed from the house
. After pets are removed, it is necessary to vacuum and wa
accumulate in large quantities (131)
. Carpets and upholstery must be cleaned and bedding was
When a patient chooses to keep the cat/dog indoors
. A vacuum cleaner equipped with HEPA filter and double
reservoir
. Carpeting must be removed from all indoor environments
. Use a high eciency particulate air cleaner (HEPA) for re
. Pets should be washed twice a week to reduce Fel d 1 (13
. Pet bedding should be washed together with animals
. Pets must be keep outdoors as longer as possible
. Pets must not be allowed to stay in the bedroom or living
. Natural ventilation of indoor environments is necessary
. Clothes contaminated with allergen must be frequently waallergens in a cat-free environment (71). Washing in water is
able to completely abolish the amounts of cat allergen from
contaminated cotton webs. Consequently this procedure, in
association with avoidance of using allergen-contaminated
clothes outdoors, is a means for preventing the dispersal of
cat allergen (104).
COCKROACHES
The available methods to control cockroach populations
are generally considered ecient. Entomological literature
shows that the degree of extermination is up to 100%.
These results may last for almost 3 months (105). However,
medical literature reports high amounts of Bla g 1 in dust of
indoor environments after recent cockroach extermination
by the use of chemical agents (106). In effect, an intensive
vacuum cleaning is necessary to remove cockroach materi-
als containing active allergen proteins after the extermina-
tion process (107,108).
The National Cooperative Inner-City Asthma Study
(NCICAS) has recently carried out a phase II study using a
broad-based intervention to reduce asthma morbidity in
cockroach-sensitized asthmatic children (109). A combina-
tion of education, cleaning and extermination with Aba-
mectin (Avert) was used to try to reduce indoor levels of
cockroach allergen (Bla g 1) in the kitchen, bedroom and
living room. The results of this study demonstrate that
removal of cockroach allergen from indoor environments is
not an easy task. Moreover, it has been clearly shown that,
despite a significant but short-lasting decrease, the amounts
of cockroach allergens remained well above levels pre-
viously found to be clinically significant (109). Conse-
quently a long-term treatment of indoor environments is
likely to be needed for decreasing the level of cockroach
allergens and new techniques to prevent reinfestations
should also be challenged (109).
The need for frequent use of chemical agents for the
extermination of cockroaches requires adequate studies for
excluding possible side-effects on human health. Table 5/dog
sh all surfaces including wall surfaces on which Fel d 1 may
hed
thickness bags must be used for removing pet allergens from
and replaced with linoleum or wood flooring
moving airborne Can f 1/Fel d 1 allergens (49,132)
3,134) and Can f 1 (135) shedding
room
shed (104)
TABLE 5. Measures to minimize exposure to cockroach allergens
. Remove waste food and water leakage which facilitate the growth of cockroach populations
. The integrity of plasterworks and floors should be controlled to avoid cockroaches access indoors
. Use available chemical agents for cockroach extermination (diazinon, chlorpyrifos, hydramethylnon, abamectin etc.) in
different formulations (bait stations, paste etc.)
. Use an intensive vacuum cleaning for removing cockroach materials after extermination with chemical agents
. Encourge patients’ compliance by adequate education programmes
1114 G. LICCARDI ET AL.indicates the main measures to minimize exposure to the
cockroach allergens.
CONCLUSIONS
There is a body of evidence suggesting that allergic
respiratory diseases, particularly bronchial asthma, have
become more common in the last two decades in
industrialized countries all over the world and are a true
problem for the Health Authorities. Nevertheless, indoor
allergens represent the major risk factor for development of
allergic sensitization of airways because these antigenic
proteins are usually inhaled in the first years of life (14,15).
Since no threshold concentrations have been defined for
any indoor allergens it is dicult to determine health
standards. For these reasons, it should be reasonable that
Health Authorities suggest the lowest levels for indoor
allergens according to the data from available studies in the
literature (51,110).
Although there are no convincing studies to address the
issue of the effectiveness of reducing exposure early in life
on atopic disorders later on (primary prevention) in the
literature, it is likely that secondary and even tertiary
prevention applied in the first years of life would be useful
with respect to delaying the clinical expression of asthma or
to reduce the frequency and/or severity of clinical
symptoms.
The use of scientifically validated avoidance measures is
crucial to obtain positive clinical results (111). Further studies
should be carried out to improve prevention strategies which
should be easier to perform and at lower cost.
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